Other languages H.U. Group Holdings, Inc.

Equities

4544

JP3822000000

Market Closed - Japan Exchange Other stock markets 02:00:00 2024-04-24 am EDT			5-day change	1st Jan Change
2,406 ^JPY	+0.38%		-0.27%	-9.67%

Mar. 13	H.U Unit Fujirebio Diagnostics Partners Beckman Coulter in Neurodegenerative Diseases Field	MT
Mar. 13	Fujirebio and Beckman Coulter Expand Partnership to Develop Patient-Friendly, Blood-Based Neurodegenerative Disease Diagnostics	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Fujirebio and Beckman Coulter Expand Partnership to Develop Patient-Friendly, Blood-Based Neurodegenerative Disease Diagnostics	Mar. 12
H.U. Group Holdings Inc. and Fujirebio Announces the Availability of the Lumipulse G pTau 217 Plasma Assay for the Fully Automated LUMIPULSE G Immunoassay Systems	Dec. 22
Japanese Shares Rebound After Inflation Data, BoJ Rate Outlook	Dec. 22
H.U. Group to Issue Stock Options to Directors, Employees	Dec. 21
H.U. Group to Grant Share Options to Staff	Nov. 19
H.U. Group Holdings, Inc. Revises Earnings Guidance for the Fiscal Year Ending March 31, 2024	Nov. 09
H.U. Group Holdings' Fiscal Full-Year Profit Falls 47%	23-05-17
H.U. Group Holdings, Inc. Announces Dividend for the Year Ended March 31, 2023, Payable on May 30, 2023; Provides Dividend Guidance for the Second Quarter and Full Year Ending March 31, 2024	23-05-16
H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2024	23-05-16
H.U. Group Holdings, Inc. Reports Earnings Results for the Full Year Ended March 31, 2023	23-05-12
H.U. Group Holdings, Inc. Announces Launch of the Fully Automated Lumipulse® G NfL CSF and Lumipulse® G NfL Blood tests	23-03-28
H.U. Group Holdings, Inc. Provides Consolidated Earnings Forecasts for the Fiscal Year Ending March 31, 2023	23-02-10
H.U. Group Holdings, Inc. Provides Year End Dividend Forecast for the Fiscal Year Ending March 31, 2023	23-02-10
H.U. Group Holdings, Inc. Provides Dividend Guidance for the Second Quarter-End and for the Full Year of Fiscal Year Ending March 31, 2023	22-08-15
H.U. Group Holdings, Inc. Provides Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2023	22-08-15
Japan Equities End Week Higher; W-Scope Zooms 12% on Securing Approval for Unit's Listing in Korea	22-06-24
H.U. Group Unit to Acquire Biomarker Assays Developer for $42 million	22-06-24
H.U. Group Holdings, Inc. Provides Dividend Guidance for the Fiscal Year Ended March 31, 2022	22-05-20
H.U. Group Holdings, Inc. Announces Board Changes	22-04-22
H.U. Group Holdings, Inc. Announces Launch of Fully Automated Lumipulse G ß-Amyloid 1-42 and ß-Amyloid 1-40 Plasma Assays for Research Use Only	22-03-30

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages H.U. Group Holdings, Inc.

Equities

4544

JP3822000000

Other languages

Filters